Literature DB >> 25997932

Spontaneous Aortic Regurgitation and Valvular Cardiomyopathy in Mice.

Georges P Hajj1, Yi Chu1, Donald D Lund1, Jason A Magida1, Nathan D Funk1, Robert M Brooks1, Gary L Baumbach1, Kathy A Zimmerman1, Melissa K Davis1, Ramzi N El Accaoui1, Tariq Hameed1, Hardik Doshi1, BiYi Chen1, Leslie A Leinwand1, Long-Sheng Song1, Donald D Heistad2, Robert M Weiss2.   

Abstract

OBJECTIVE: We studied the mechanistic links between fibrocalcific changes in the aortic valve and aortic valve function in mice homozygous for a hypomorphic epidermal growth factor receptor mutation (Wave mice). We also studied myocardial responses to aortic valve dysfunction in Wave mice. APPROACH AND
RESULTS: At 1.5 months of age, before development of valve fibrosis and calcification, aortic regurgitation, but not aortic stenosis, was common in Wave mice. Aortic valve fibrosis, profibrotic signaling, calcification, osteogenic markers, lipid deposition, and apoptosis increased dramatically by 6 and 12 months of age in Wave mice. Aortic regurgitation remained prevalent, however, and aortic stenosis was rare, at all ages. Proteoglycan content was abnormally increased in aortic valves of Wave mice at all ages. Treatment with pioglitazone prevented abnormal valve calcification, but did not protect valve function. There was significant left ventricular volume overload, hypertrophy, and fetal gene expression, at all ages in Wave mice with aortic regurgitation. Left ventricular systolic function was normal until 6 months of age in Wave mice, but became impaired by 12 months of age. Myocardial transverse tubules were normal in the presence of left ventricular hypertrophy at 1.5 and 3 months of age, but became disrupted by 12 months of age.
CONCLUSIONS: We present the first comprehensive phenotypic and molecular characterization of spontaneous aortic regurgitation and volume-overload cardiomyopathy in an experimental model. In Wave mice, fibrocalcific changes are not linked to valve dysfunction and are epiphenomena arising from structurally incompetent myxomatous valves.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  aortic regurgitation; aortic stenosis; aortic valve disease; cardiomyopathy

Mesh:

Substances:

Year:  2015        PMID: 25997932      PMCID: PMC4482792          DOI: 10.1161/ATVBAHA.115.305729

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  26 in total

1.  Mice mutant for Egfr and Shp2 have defective cardiac semilunar valvulogenesis.

Authors:  B Chen; R T Bronson; L D Klaman; T G Hampton; J F Wang; P J Green; T Magnuson; P S Douglas; J P Morgan; B G Neel
Journal:  Nat Genet       Date:  2000-03       Impact factor: 38.330

Review 2.  Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies.

Authors:  Rosario V Freeman; Catherine M Otto
Journal:  Circulation       Date:  2005-06-21       Impact factor: 29.690

Review 3.  Fibrocalcific aortic valve disease: opportunity to understand disease mechanisms using mouse models.

Authors:  Robert M Weiss; Jordan D Miller; Donald D Heistad
Journal:  Circ Res       Date:  2013-07-05       Impact factor: 17.367

4.  ErbB2 is essential in the prevention of dilated cardiomyopathy.

Authors:  Steven A Crone; You-Yang Zhao; Lian Fan; Yusu Gu; Susumu Minamisawa; Yang Liu; Kirk L Peterson; Ju Chen; Ronald Kahn; Gianluigi Condorelli; John Ross; Kenneth R Chien; Kuo-Fee Lee
Journal:  Nat Med       Date:  2002-05       Impact factor: 53.440

Review 5.  Current management of calcific aortic stenosis.

Authors:  Brian R Lindman; Robert O Bonow; Catherine M Otto
Journal:  Circ Res       Date:  2013-07-05       Impact factor: 17.367

6.  Insufficient versican cleavage and Smad2 phosphorylation results in bicuspid aortic and pulmonary valves.

Authors:  Loren E Dupuis; Hanna Osinska; Michael B Weinstein; Robert B Hinton; Christine B Kern
Journal:  J Mol Cell Cardiol       Date:  2013-03-24       Impact factor: 5.000

7.  Alterations in gene expression in the rat heart after chronic pathological and physiological loads.

Authors:  P M Buttrick; M Kaplan; L A Leinwand; J Scheuer
Journal:  J Mol Cell Cardiol       Date:  1994-01       Impact factor: 5.000

8.  Overexpression of junctophilin-2 does not enhance baseline function but attenuates heart failure development after cardiac stress.

Authors:  Ang Guo; Xiaoying Zhang; Venkat Ramesh Iyer; Biyi Chen; Caimei Zhang; William J Kutschke; Robert M Weiss; Clara Franzini-Armstrong; Long-Sheng Song
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

9.  The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase.

Authors:  N C Luetteke; H K Phillips; T H Qiu; N G Copeland; H S Earp; N A Jenkins; D C Lee
Journal:  Genes Dev       Date:  1994-02-15       Impact factor: 11.361

10.  Gene profiling of left ventricle eccentric hypertrophy in aortic regurgitation in rats: rationale for targeting the beta-adrenergic and renin-angiotensin systems.

Authors:  Serge Champetier; Azadeh Bojmehrani; Jonathan Beaudoin; Dominic Lachance; Eric Plante; Elise Roussel; Jacques Couet; Marie Arsenault
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-12-26       Impact factor: 4.733

View more
  4 in total

1.  Wave mice: a new tool in the quest to characterize aortic valvular disease etiologies.

Authors:  Ana M Porras; Kristyn S Masters
Journal:  J Thorac Dis       Date:  2015-09       Impact factor: 2.895

2.  Aortic regurgitation and heart valve disease in mice.

Authors:  Yong Fen Qi
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

3.  S2 Heart Sound Detects Aortic Valve Calcification Independent of Hemodynamic Changes in Mice.

Authors:  Valentina Dargam; Hooi Hooi Ng; Sana Nasim; Daniel Chaparro; Camila Iansen Irion; Suhas Rathna Seshadri; Armando Barreto; Zachary C Danziger; Lina A Shehadeh; Joshua D Hutcheson
Journal:  Front Cardiovasc Med       Date:  2022-05-25

4.  Discovery of an Experimental Model of Unicuspid Aortic Valve.

Authors:  Robert M Weiss; Yi Chu; Robert M Brooks; Donald D Lund; Justine Cheng; Kathy A Zimmerman; Melissa K Kafa; Phanicharan Sistla; Hardik Doshi; Jian Q Shao; Ramzi N El Accaoui; Catherine M Otto; Donald D Heistad
Journal:  J Am Heart Assoc       Date:  2018-06-30       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.